REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
02/02/2026
Back to search
Official data from USPTO
NEURAXPHARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
02/03/2026
Classification
Registered
Trademark type
Combined
Nice classes
5, 35, 42
Filing date
03/19/2020
Registration date
02/02/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/02/2021
Last transaction
02/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
ES
Examiner
MICKLEBURGH, LINDA BOHANNON
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the term "NEURAXPHARM" in black font to the right of a blue cog-like design.
Holders and representatives
Holders
NEURAXPHARM HOLDCO IBERIA, S.L.
Representatives
Angel Miguel Munoz, Esq. Munoz-Lopez & Associates PLLC
Technical classification
Nice Classes
Class 5Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productspreparations for medical and veterinary usenamely dropsoral solutionscapsulestablets and compressed tablets acting on the central nervous system; dietetic food adapted for medical or veterinary use; food for babies; food supplements for humans or animals; plasters for woundswound dressings; teeth filling and dental impression materials; disinfectants; preparations for destroying vermin; fungicidesherbicides
Class 35
Commercial business managementadvertising and marketing; commercial mediation services for contracts; organization of exhibitions and trade fairs for commercial or advertising purposes; import and export services; retail and wholesale store services and online retail and wholesale store services for medical and pharmaceutical productshygienic and sanitary products for medical usedietetic substances and foodstuffs for medical or veterinary usefood for babies
Class 42
Scientific and technological servicesscientific researchanalysis and testing in the field of pharmaceutical products for the central nervous system; laboratory research services relating to pharmaceutical products; pharmaceutical research and development services; pharmaceutical product efficacy assessment services for others
Publications
History of USPTO decisions and trademark events.
25 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/30/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/30/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/30/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/30/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/05/2021
FIMP
FINAL DISPOSITION PROCESSED
05/05/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/02/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
02/02/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/17/2020
PUBO
PUBLISHED FOR OPPOSITION
11/17/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/28/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/09/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/07/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/07/2020
RFNT
REFUSAL PROCESSED BY IB
08/14/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/29/2020
RFRR
REFUSAL PROCESSED BY MPU
07/29/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/18/2020
CNRT
NON-FINAL ACTION WRITTEN
06/17/2020
DOCK
ASSIGNED TO EXAMINER
06/10/2020
MAFR
APPLICATION FILING RECEIPT MAILED
04/24/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/20/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/16/2020
Continuous trademark protection
Get notified about every new filing that threatens NEURAXPHARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.